The differential mRNA expression analysis of genes included in the AVENIO surveillance panel demonstrated that MET, EGFR, SLPI, and TNFRSF21 had the highest difference in log2(TPM + 1) between NSCLC tumours and PBMCs (Fig. S5). This evidence concerns the gene MET and non-small cell lung carcinoma.